title: [Can the correct dose be predicted by phase III?].
authors.affiliation: Laboratoire Astra, Nanterre.
authors.forename: R
authors.initials: R
authors.lastname: Dahan
authors.forename: P
authors.initials: P
authors.lastname: Jaillon
authors.forename: J P
authors.initials: JP
authors.lastname: Lehner
mesh_terms: D017322:Clinical Trials, Phase II as Topic / Q000379:methods*; D017326:Clinical Trials, Phase III as Topic / Q000379:methods*; D004305:Dose-Response Relationship, Drug; D006801:Humans; D016032:Randomized Controlled Trials as Topic
vernacular_title: Peut-on prédire la bonne posologie de la phase III?